
Epristeride
CAS No. 119169-78-7
Epristeride( —— )
Catalog No. M33351 CAS No. 119169-78-7
Epristeride (ONO-9302) is an orally active, selective and non-competitive steroidal 5-α-reductase isoform 2 inhibitor that inhibits SR isoform 2.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 152 | Get Quote |
![]() ![]() |
5MG | 235 | Get Quote |
![]() ![]() |
10MG | 376 | Get Quote |
![]() ![]() |
25MG | 731 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEpristeride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpristeride (ONO-9302) is an orally active, selective and non-competitive steroidal 5-α-reductase isoform 2 inhibitor that inhibits SR isoform 2.
-
DescriptionEpristeride (ONO-9302) is a selective, specific and orally active uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2. Epristeride has inhibitory effects for SR isoenzymes types 2 with Ki value of 0.7-2 nM. Epristeride can be used for the research of prostatic hyperplasia and acne.
-
In VitroEpristeride has inhibitory effects for SR isoenzymes types 2 (SR2) with Ki values of 0.7-2 nM.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | Reductase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number119169-78-7
-
Formula Weight399.57
-
Molecular FormulaC25H37NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (250.27 mM; Ultrasonic )
-
SMILES[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C=C(CC[C@]12C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M A Levy, et al. Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2. J Steroid Biochem Mol Biol. 1994 Feb;48(2-3):197-206.?
molnova catalog



related products
-
Daporinad hydrochlor...
Daporinad hydrochloride (FK 866 hydrochloride) is a potent nicotinamide-phosphate ribosyltransferase (NAMPT) inhibitor with potential anti-tumor and anti-angiogenic activity that induces apoptosis in tumor cells.
-
TAS6417
TAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC.
-
Puromycin aminonucle...
Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.Puromycin aminonucleoside -induced podocyte apoptosis is p53 dependent. Puromycin aminonucleoside causes podocyte apoptosis in a time-dependent manner.